Pfizer, Moderna Vaccines Less Effective Against Delta In Elderly And Protection Wanes Rapidly Four Months After Second Covid Shot, Study FindsForbes • 12/15/21
U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing SpondylitisBusiness Wire • 12/14/21
South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine ProtectionBenzinga • 12/14/21
Two doses of Pfizer's vaccine cut the risk of hospitalization by 70% during Omicron surge, real-world data from South Africa showedBusiness Insider • 12/14/21
Pfizer says its oral COVID-19 pill can help prevent severe infection from the Omicron variantBusiness Insider • 12/14/21
Pfizer's acquisition of Arena "shows big pharma's interest in cannabinoid medicines"Proactive Investors • 12/14/21
Pfizer says final data from late-stage trial of COVID-19 antiviral shows it reduces risk of hospitalization or death by 89%Market Watch • 12/14/21
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or DeathBusiness Wire • 12/14/21
Cathie Wood Sells $8.6M Worth Shares In Pfizer, Buys Coinbase And Robinhood On The DipBenzinga • 12/14/21
Pfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study FindsForbes • 12/14/21
South Africa study shows two Pfizer shots may halt 70% of omicron hospitalizations: reportMarket Watch • 12/14/21